Skip to main content
Indivior PLC logo

Indivior PLC — Investor Relations & Filings

Ticker · INDV ISIN · GB00BN4HT335 LEI · 213800V3NCQTY7IED471 IL Manufacturing
Open in API
Filings indexed 1,983 across all filing types
Latest filing 2024-05-24 Regulatory Filings
Country GB United Kingdom
Listing IL INDV

About Indivior PLC

https://www.indivior.com/en

Indivior PLC is a global pharmaceutical company that develops, manufactures, and sells medicines to treat substance use disorders (SUD) and serious mental illnesses. The company's primary focus is on pioneering treatments for opioid use disorder (OUD), with a portfolio centered on buprenorphine-based prescription pharmaceuticals. Through its research and development efforts, Indivior aims to address the complex challenges of addiction and behavioral health by providing innovative, life-transforming therapies for patients worldwide.

Recent filings

Filing Released Lang Actions
TRANSACTION IN OWN SHARES
Regulatory Filings
2024-05-24 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is titled 'INDIVIOR PLC TRANSACTIONS IN OWN SHARES' and explicitly details the purchase of ordinary shares for cancellation on May 23, 2024, including volume, high/low/VWAP prices, and a full breakdown of individual purchases. This directly corresponds to the definition of a report detailing the company buying back or selling its own shares. This matches the 'Transaction in Own Shares' category (POS). The RNS Number (7364P) confirms it is a regulatory announcement, but the content is specific enough to classify it as POS rather than the general RNS fallback.
2024-05-24 English
RESULT OF GENERAL MEETING
Regulatory Filings
2024-05-23 English
Special Resolution Passed at the 2024 General Meeting Held on May 23, 2024
Regulatory Filings Classification · 85% confidence The provided document text is completely empty ("---" only, with a reported length of 9 characters). This indicates either a metadata error or an extremely minimal filing. Given the lack of content, it cannot be classified as any specific financial report (10-K, IR, ER, etc.). Following the principle of classifying based on available evidence, and recognizing that an empty document does not constitute a substantive report, the most appropriate classification is the general fallback category for miscellaneous or unclassifiable regulatory filings, which is RNS.
2024-05-23 English
Result of General Meeting
AGM Information Classification · 99% confidence The document is an official announcement disseminated via RNS (RNS Number: 7023P) from Indivior PLC, dated May 23, 2024. The core content explicitly states the 'Result of General Meeting' and details the voting outcome for a specific resolution (transfer of listing category). This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it is distributed via RNS, the specific content is a vote result, making DVA the most precise classification over the general RNS fallback.
2024-05-23 English
INDIVIOR RECONFIRMS FULL YEAR 2024 GUIDANCE
Regulatory Filings
2024-05-23 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.